Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults

Completed · Phase 2 · Has a placebo group

Conditions studied: Invasive Meningococcal Disease

In brief

This study will evaluate the safety and immunogenicity of combination vaccines as compared to the reference vaccines

Key facts

Study ID
NCT01272180
Run by
Novartis Vaccines
People needed
484
Starts
2011-08-01
Expected to finish
2012-09-01
Last updated by the study team
2020-06-16

Who can join

Age: 10 and older, up to 25. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.